Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.



Question
Octreotide may have a marginal benefit by decreasing the rate of nonvariceal bleeding, but it is inferior to intravenous proton pump inhibitors. Octreotide is most useful in patients with [...] bleeding
Answer
variceal

Question
Octreotide may have a marginal benefit by decreasing the rate of nonvariceal bleeding, but it is inferior to intravenous proton pump inhibitors. Octreotide is most useful in patients with [...] bleeding
Answer
?

Question
Octreotide may have a marginal benefit by decreasing the rate of nonvariceal bleeding, but it is inferior to intravenous proton pump inhibitors. Octreotide is most useful in patients with [...] bleeding
Answer
variceal
If you want to change selection, open original toplevel document below and click on "Move attachment"

Parent (intermediate) annotation

Open it
Octreotide may have a marginal benefit by decreasing the rate of nonvariceal bleeding, but it is inferior to intravenous proton pump inhibitors. Octreotide is most useful in patients with variceal bleeding

Original toplevel document (pdf)

owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p2594

Summary

statusnot learnedmeasured difficulty37% [default]last interval [days]               
repetition number in this series0memorised on               scheduled repetition               
scheduled repetition interval               last repetition or drill

Details

No repetitions


Discussion

Do you want to join discussion? Click here to log in or create user.